115 results

Cement-maker CRH, the largest stock on the Dublin market, dropped 2.2 per cent to €31.50. Photograph: Brenda Fitzsimons

European shares fell yesterday, weighed down by falls for banking stocks. An early rally deflated as a more cautious mood took hold later in the sess(...)

Wednesday sees the S&P 500 dipping 6.5 points to 2,174 as investors look warily at a continuation of the “Trumpflation trade”.

US and European stocks are softer in Wednesday afternoon trading as the dollar hits a 13-year high and bond yields touch multimonth peaks with investo(...)

Video-grab of  BBC journalist John Simpson reporting after a bomb was dropped on a convoy of US and Kurdish forces  near Mosul, northern Iraq, on  April 6th, 2003

For your diary MONDAY Indicators: Irish consumer confidence (Sept); German Markit manufacturing PMI (Sept); Euro zone Markit manufacturing PMI (Sept(...)

This year’s largest deal so far, Bayer’s $66 billion takeover of Monsanto, was clinched in the third quarter.

The value of announced mergers and acquisitions (M&A) worldwide fell 27 per cent year-on-year to $753 billion in the third quarter of 2016, as app(...)

Liam Condon, head of Bayer AG’s crop science division: “GM acceptance in Europe is exceptionally low and . . . it’s something we have to accept.”

Dubliner Liam Condon is a marathon man. And the Navan Road native is now limbering up for the run of his life: to seal one of the largest corporate t(...)

Luxury goods group Burberry fell 2.1 per cent on the back of cautious updates from rivals such as Hermes and Richemont. Photograph: PA

Equities have been under pressure after the European Central Bank said last week that an extension of its stimulus programme had not been discussed, (...)

Monsanto’s shares ended 0.8 per cent lower at $106.10 in New York on Tuesday amid uncertainty over whether any agreed deal will clear antitrust hurdles. Photograph: Brendan McDermid/Reuters

Bayer is bracing itself for tough regulatory scrutiny of its $66 billion deal to acquire Monsanto, which will transform the German aspirin-to-chemical(...)

A deal with Monsanto would give Bayer a shot at grabbing the top spot in the fast-consolidating farm supplies industry. Photograph: Brendan McDermid/Reuters

German pharmaceutical and crops manufacturer Bayer said its negotiations with Monsanto Co had advanced, and it was now willing to offer more than $65 (...)

Syngenta had said in July it expected the deal to close this year despite concerns that US regulators could throw a spanner in the works

A US regulator has cleared ChemChina’s $43 billion takeover of Swiss pesticides and seeds group Syngenta, the companies said on Monday, boosting chanc(...)

Bayer’s  pharmaceutical division continues to grow, with sales in 2016 likely to top €16 billion.

Bayer, the German chemicals company seeking to acquire Monsanto, reported a 5.7 per cent increase in second-quarter profit as prescription-drug sales (...)

  • « First
  • Prev
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next
  • Last »